Vlad Coric - 05 Jan 2025 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
05 Jan 2025
Net transactions value
-$262,945
Form type
4
Filing time
07 Jan 2025, 20:48:39 UTC
Previous filing
03 Oct 2024
Next filing
06 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $0 +14,250 +0.8% $0.000000 1,803,409 05 Jan 2025 Direct
transaction BHVN Common Shares Tax liability $262,945 -6,805 -0.38% $38.64 1,796,604 05 Jan 2025 Direct F1
holding BHVN Common Shares 861,942 05 Jan 2025 By: The Vlad Coric Family Trust F2
holding BHVN Common Shares 407,213 05 Jan 2025 By: The Vladimir Coric Marital Trust F2
holding BHVN Common Shares 109,565 05 Jan 2025 By: 401(K) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to buy) Award $0 +343,000 $0.000000 343,000 05 Jan 2025 Common Shares 343,000 $38.64 Direct F3
transaction BHVN Restricted Share Unit Award Award $0 +57,000 $0.000000 57,000 05 Jan 2025 Common Shares 57,000 Direct F4, F5, F6
transaction BHVN Restricted Share Unit Award Options Exercise $0 -14,250 -25% $0.000000 42,750 05 Jan 2025 Common Shares 14,250 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
F2 These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
F4 Each restricted share unit represents the contingent right to receive one common share of the Issuer.
F5 The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
F6 Not applicable.